OREANDA-NEWS. uniQure N.V. (NASDAQ: QURE), a leader in human gene therapy, today announced that Matt Kapusta, interim chief executive officer, will present an overview of the company's programs and progress at the Jefferies Gene Editing/Gene Therapy Summit on Tuesday October 11th at the Jefferies Conference Center in New York City:

  • Jefferies Gene Editing/ Gene Therapy Summit
    Venue: Jefferies Conference Center, New York City
    Presenter: Matt Kapusta, Interim Chief Executive Officer
    Date and Time: Tuesday, October 11th, 2:00 p.m. EDT

About uniQure
uniQure is delivering on the promise of gene therapy - single treatments with potentially curative results. We are leveraging our modular and validated technology platform to rapidly advance a pipeline of proprietary and partnered gene therapies to treat patients with CNS, liver/metabolic and cardiovascular diseases.